B-cell lymphoma 2 (BCL-2) is an antiapoptotic protein that plays a key role in the survival and therapeutic resistance of AML cells, including the leukemia stem cell (LSC) population [5,6]. Here, BCL2 is linked to acute myeloid leukemia.